Sam­sung Bi­o­log­ics pro­motes new CEO from with­in to head next phase of rapid man­u­fac­tur­ing ex­pan­sion

Rid­ing a wave of red-hot in­vest­ments in bi­o­log­ics, Sam­sung Bi­o­log­ics — the bio­phar­ma CD­MO arm of the South Ko­re­an tech gi­ant — is string­ing to­geth­er a se­ries …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER